Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

Why Clinicians Worry Medicare’s New $50 Weight-Loss Program Could Backfire

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Medicare will start covering obesity drugs for the first time. Here's what patients should know

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns?

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

Here's what to know about Medicare's new GLP-1 weight-loss drug program

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Medicare will begin covering weight loss drugs Wednesday. There’s a catch.

The program, which will make weight loss drugs eligible for people on Medicare for $50 a month, is set to run for only 18 ...

Medicare will start covering weight-loss drugs on July 1 for the first time. Here’s what you need to know

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...
Everyday Health on MSN

New Medicare GLP-1 bridge program to offer weight loss meds for $50 a month

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...